ECSP034579A - COMBINATION OF ADJUSTMENT FORMULATIONS - Google Patents
COMBINATION OF ADJUSTMENT FORMULATIONSInfo
- Publication number
- ECSP034579A ECSP034579A ECSP034579A ECSP034579A EC SP034579 A ECSP034579 A EC SP034579A EC SP034579 A ECSP034579 A EC SP034579A EC SP034579 A ECSP034579 A EC SP034579A
- Authority
- EC
- Ecuador
- Prior art keywords
- combination
- formulations
- adjustment
- glucosaline
- granulite
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Este invento se refiere al uso de un compuesto de aminoalquilo glucosalina fosfato o un derivado o análogo del mismo, en combinación con una linfoquina, en particular un factor estimulante de la colonia de granulcito macrófago o interleuquin-12, como formulación adyuvante en una composición antígenico o inmunogénico para mejorar la respuesta inmunológico de un huésped vertebrado a un antígeno seleccionado.This invention relates to the use of an aminoalkyl glucosaline phosphate compound or a derivative or analog thereof, in combination with a lymphokine, in particular a stimulating factor of the macrophage or interleukin-12 granulite colony, as an adjuvant formulation in an antigenic composition. or immunogenic to improve the immune response of a vertebrate host to a selected antigen.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24710000P | 2000-11-10 | 2000-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034579A true ECSP034579A (en) | 2003-08-29 |
Family
ID=34115118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034579 ECSP034579A (en) | 2000-11-10 | 2003-05-08 | COMBINATION OF ADJUSTMENT FORMULATIONS |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR031211A1 (en) |
| EC (1) | ECSP034579A (en) |
| MY (1) | MY142635A (en) |
| SA (1) | SA02230071B1 (en) |
| ZA (1) | ZA200304479B (en) |
-
2001
- 2001-11-05 AR ARP010105175A patent/AR031211A1/en unknown
- 2001-11-06 MY MYPI20015089 patent/MY142635A/en unknown
-
2002
- 2002-04-20 SA SA02230071A patent/SA02230071B1/en unknown
-
2003
- 2003-05-08 EC ECSP034579 patent/ECSP034579A/en unknown
- 2003-06-09 ZA ZA200304479A patent/ZA200304479B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR031211A1 (en) | 2003-09-10 |
| SA02230071B1 (en) | 2008-11-17 |
| ZA200304479B (en) | 2004-09-09 |
| MY142635A (en) | 2010-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2364724E (en) | Vaccine compositions comprising a saponin adjuvant | |
| DK1187629T3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| NZ506603A (en) | Adjuvant compositions comprising polyoxyethylene ether or polyoxyethylene ester | |
| IS4518A (en) | New vaccine formulation | |
| FR2781159B1 (en) | CIRCOVIRUS VACCINE AND PIG PARVOVIRUS | |
| CY1112698T1 (en) | IMMUNE COMPOSITION | |
| PT777490E (en) | ENTEROTOXIN EFFECTIVE MUTANT AS A NON-TOXIC ORAL ADJUVANT | |
| EP2275124A3 (en) | Protein-based streptococcus pneumoniae vaccines | |
| DK1259259T3 (en) | Mucosal adjuvant formulation | |
| GB2386072A (en) | Novel vaccine | |
| IL146382A0 (en) | Adjuvant combination formulations | |
| ECSP034579A (en) | COMBINATION OF ADJUSTMENT FORMULATIONS | |
| HK1138516A1 (en) | Parenteral vaccine formulations and uses thereof | |
| WO2002038177A3 (en) | Adjuvant combination formulations | |
| UY27016A1 (en) | ADJUSTER COMBINATION FORMULATIONS | |
| AU6761301A (en) | Adjuvant composition comprising fha protein or fragment of fha protein in free form | |
| DK1401492T3 (en) | LTB4 as a vaccine adjuvant |